Short stature and therapy;Kleinwuchs und therapie

Monatsschrift fur Kinderheilkunde

Volumn 162, Issue 4, 2014, Pages 299-308

  Binder, G ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Growth disorders; Growth hormone deficiency; Infant, small for gestational age; Priming; Turner syndrome

Indexed keywords

GROWTH HORMONE;

ARTICLE; BODY HEIGHT; BONE AGE; CHILD DEVELOPMENT; CHILD GROWTH; CLINICAL ASSESSMENT; GENE; GROWTH CURVE; GROWTH DISORDER; GROWTH HORMONE DEFICIENCY; GROWTH RATE; HORMONAL THERAPY; HUMAN; MEDICAL HISTORY; MEDICAL SPECIALIST; PATIENT REFERRAL; PROVOCATION TEST; PUBERTY; SHORT STATURE; SHOX GENE; SMALL FOR DATE INFANT; TURNER SYNDROME;

EID: 84897560068     PISSN: 00269298     EISSN: 14330474     Source Type: Journal    
DOI: 10.1007/s00112-013-3044-y     Document Type: Article

References (27)

1. Bayley N, Pinneau SR (1952) Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards. J Pediatr 40:423-441
2. Binder G, Ranke MB, Martin DD (2003) Auxology is a valuable instrument for the clinical diagnosis of SHOX haploinsufficiency in school-age children with unexplained short stature. J Clin Endocrinol Metab 88:4891-4896 (Pubitemid 37357540)
3. Binder G (2011) Short stature due to SHOX deficiency: genotype, phenotype, and therapy. Horm Res Paediatr 75:81-89
4. Binder G, Brämswig JH, Kratzsch J et al (2008) Leitlinie zur Diagnostik des Wachstumshormonmangels im Kindes- und Jugendalter. AWMF-Leitlinien- Register Nr. 089/001 Entwicklungsstufe: 2 (wird 2014 überprüft). http://www.awmf.org/leitlinien/detail/ll/089-001.html
5. Binder G, Weidenkeller M, Blumenstock G et al (2010) Rational approach to the diagnosis of severe growth hormone deficiency in the newborn. J Clin Endocrinol Metab 95:2219-2226
6. Binder G, Huller E, Blumenstock G, Schweizer R (2011) Auxology-based cut-off values for biochemical testing of GH secretion in childhood. Growth Horm IGF Res 21:212-218
7. Blum WF, Crowe BJ, Quigley CA et al (2007) Growth hormone is effective in treatment of short stature associated with short stature homeobox-containing gene deficiency: two-year results of a randomized, controlled, multicenter trial. J Clin Endocrinol Metab 92:219-228 (Pubitemid 46067535)
8. Carel JC, Elie C, Ecosse E et al (2006) Self-esteem and social adjustment in young women with Turner syndrome - influence of pubertal management and sexuality: population-based cohort study. J Clin Endocrinol Metab 91:2972-2979 (Pubitemid 44271744)
9. Cutfield WS, Wilton P, Bennmarker H et al (2000) Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment. Lancet 355:610-613 (Pubitemid 30099467)
10. Darendeliler F, Karagiannis G, Wilton P (2007) Headache, idiopathic intracranial hypertension and slipped capital femoral epiphysis during growth hormone treatment: a safety update from the KIGS database. Horm Res 68(Suppl 5):41-47
11. Greulich WW, Pyle SI (1959) Radiographic atlas of skeletal development of the hands and wrists, 2. Aufl. Stanford University Press, Stanford
12. Grote FK, Dommelen P van, Oostdijk W et al (2008) Developing evidence-based guidelines for referral for short stature. Arch Dis Child 93:212-217 (Pubitemid 352025491)
13. Karlberg J (1989) A biologically-oriented mathematical model (ICP) for human growth. Acta Paediatr Scand Suppl 350:70-94
14. Marin G, Domené HM, Barnes KM et al (1994) The effects of estrogen priming and puberty on the GH hormone response to standardized treadmill exercise and arginine-insulin in normal girls and boys. J Clin Endocrinol Metab 79:537-541 (Pubitemid 24256549)
15. Ranke MB, Saenger P (2001) Turner's syndrome. Lancet 358:309-314 (Pubitemid 32738974)
16. Rao E, Weiss B, Fukami M et al (1997) Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome. Nat Genet 16:54-63 (Pubitemid 27198156)
17. Rikken B, Wit J (1992) Prepubertal height velocity references over a wide age range. Arch Dis Child 67:1277-1280
18. Romano AA, Allanson JE, Dahlgren J et al (2010) Noonan syndrome: clinical features, diagnosis, and management guidelines. Pediatrics 126:746-759
19. Saenger P, Czernichow P, Hughes I, Reiter EO (2007) Small for gestational age: short stature and beyond. Endocr Rev 28:219-251 (Pubitemid 46984835)
20. Schweizer R, Martin DD, Haase M et al (2007) Similar effects of long-term exogenous growth hormone (GH) on bone and muscle parameters: a pQCT study of GH-deficient and small-for-gestationalage (SGA) children. Bone 41:875-881 (Pubitemid 47576838)
21. Shah A, Stanhope R, Matthew D (1992) Hazards of pharmacological tests of growth hormone secretion in childhood. BMJ 304:173-174
22. Spiliotis BE, August GP, Hung W et al (1984) Growth hormone neurosecretory dysfunction. A treatable cause of short stature. JAMA 251:2223-2230 (Pubitemid 14135436)
23. Stephure DK, Canadian Growth Hormone Advisory Committee (2005) Impact of growth hormone supplementation on adult height in Turner syndrome: results of the Canadian randomized controlled trial. J Clin Endocrinol Metab 90:3360-3366 (Pubitemid 41014298)
24. Superti-Furga A, Unger S (2007) Nosology and classification of genetic skeletal disorders: 2006 revision. Am J Med Genet A 143:1-18 (Pubitemid 46051466)
25. Tanner JM (1985) Growth regulation and the genetics of growth. Prog Clin Biol Res 200:19-32
26. Tanner J, Whitehouse R, Marshall W et al (1975) Assessment of skeletal maturity and prediction of adult height (TW2 method). Academic Press, New York
27. Van der Eerden BC, Wit JM (2003) Systemic and local regulation of the growth plate. Endocr Rev 24:782-801